Search
Finance

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound

By: 1newsmedia.com

Date:




The CagriSema study results are a setback for the Danish drugmaker in its efforts to regain ground lost to Eli Lilly in the obesity-drug market.



Source link

Previous article
Kara Braxton, two-time WNBA champion, dies at 43
Next article
Brandi Carlile Confirms New Highwomen Album Is Coming
1newsmedia.com
1newsmedia.comhttps://1newsmedia.com

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Trump’s Friends Gave Him Tickets to World Cup, Super Bowl and Ryder Cup

1newsmedia.com 1newsmedia.com -
Federal disclosures show the president received dozens of tickets...

Fantasy baseball rankings update: Key risers and fallers

1newsmedia.com 1newsmedia.com -
Every...

Roof of tutoring center collapses in eastern Pakistan, killing at least 14 children, police say

1newsmedia.com 1newsmedia.com -
LAHORE, Pakistan -- A roof collapse at a tutoring...

High fire danger continues into July

1newsmedia.com 1newsmedia.com -
High fire danger will continue across parts of New...

About us

1 News Media is your trusted source for local news, stories, and events that matter most to our community. Based in the heart of the region, we are committed to delivering timely, accurate, and meaningful coverage—from breaking news and local government updates to community features, sports, and culture.

The latest

Trump’s Friends Gave Him Tickets to World Cup, Super Bowl and Ryder Cup

Finance 0
Federal disclosures show the president received dozens of tickets...

Fantasy baseball rankings update: Key risers and fallers

Sports 0
Every...

Roof of tutoring center collapses in eastern Pakistan, killing at least 14 children, police say

World News 0
LAHORE, Pakistan -- A roof collapse at a tutoring...

© 2026-2027 All Rights Reserved. 1 News Media